当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
HYQVIA, Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase
药品名称
HYQVIA, Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase
承诺描述
Deferred pediatric study under PREA for the treatment of primary immunodeficiency in pediatric patients 2-16 years of age.